全体要約
全身麻酔薬市場は、2022年の38億4060万米ドルから2029年には49億297万米ドルに成長すると予測されており、2023年から2029年の間に年平均成長率（CAGR）は3.6%となる見込みです。市場は、アメリカ、中国、ヨーロッパなどの地域で成長が見込まれ、主要企業にはAspen Pharma、Fresenius-Kabi、AbbVieなどが含まれます。
全身麻酔薬は、意識の可逆的な喪失を引き起こす薬剤であり、手術を容易にするために麻酔科医によって投与されます。これらの薬剤は、心臓手術、股関節および膝の置換手術、癌手術、消化器手術など、さまざまな手術で使用されます。市場は、プロポフォール、セボフルラン、レミフェンタニルなどの製品タイプや、静脈麻酔薬、吸入麻酔薬などの用途によってセグメント化されています。
関連する質問
3840.6 million USD (2022年)
3.6% (2023年から2029年)
Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, Hengrui, Xi'an Libang
心臓手術、関節置換手術、がん手術における全身麻酔の使用
概要
アメリカの全身麻酔薬市場は、2022年のXX米ドルから2029年のXX米ドルへと増加すると推定されており、2023年から2029年の間にXX%のCAGRを記録する見込みです。
中国の全身麻酔薬市場は、2022年のXX米ドルから2029年までにXX米ドルに増加することが見込まれており、2023年から2029年までの年間平均成長率はXX%です。
ヨーロッパの一般麻酔薬市場は、2022年のXX米ドルから2029年までにXX米ドルに増加する見込みであり、2023年から2029年までのCAGRはXX%です。
グローバルな主要な一般麻酔薬のプレイヤーには、アスペンファーマ、フレゼニウス・カービ、アッヴィ、バクスター・ヘルスケア、B.Braun、マルイシ、ピラマル、ヒクマ・ファーマシューティカルズ、そして宜昌人和（Yichang Humanwell）などが含まれます。収益の面では、2022年には、世界の二大企業がほぼXX%のシェアを占めました。
全身麻酔薬は、可逆的な意識喪失を引き起こす能力を持つ薬剤です。麻酔科医は、手術を円滑に進めるために、これらの薬剤を使用して全身麻酔を誘導または維持します。これらの薬剤のいくつかは、痛み管理のために低用量で使用されることもあります。全身麻酔は、さまざまな心臓手術、股関節および膝の置換手術、がん手術、消化器官手術に使用されます。
LPI (LP Information)の最新のリサーチレポート「一般麻酔薬産業予測」は、過去の販売を調査し、2022年の世界の一般麻酔薬の販売総額をレビューしています。また、2023年から2029年までの予測される一般麻酔薬の販売に関する地域別および市場セクター別の包括的な分析を提供。地域、市場セクター、およびサブセクターごとに分解された一般麻酔薬の販売を含むこのレポートは、世界の一般麻酔薬産業の詳細な分析をUS$百万単位で提供します。
このインサイトレポートは、世界の全身麻酔薬市場の包括的な分析を提供し、製品セグメンテーション、企業形成、収益、市場シェア、最新の動向、およびM&A活動に関連する重要なトレンドを明らかにします。また、このレポートは、全身麻酔薬ポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要なグローバル企業の戦略を分析し、加速するグローバル全身麻酔薬市場におけるこれらの企業の独自の立ち位置をよりよく理解します。
このインサイトレポートは、全身麻酔薬のグローバルな展望を形成する主要な市場動向、ドライバー、および影響要因を評価し、タイプ、用途、地域、市場規模別に予測を分解して、新たな機会のポケットを強調します。何百ものボトムアップの定性的および定量的市場インプットに基づいた透明な方法論を用いて、この研究予測は、グローバルな全身麻酔薬における現在の状態と将来の軌道に関する非常に細やかな視点を提供します。
この報告書は、一般麻酔薬市場に関する製品タイプ、用途、主要プレーヤー、主要地域および国別の包括的な概要、市場シェア、成長機会を提示しています。
市場セグメンテーション：
タイプ別セグメンテーション
プロポフォール
セボフルラン
レミフェンタニル
エトミデート
イソフルラン
その他
用途別セグメンテーション
静脈麻酔薬
吸入麻酔薬
このレポートは、地域別に市場を分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下のプロフィールが紹介されている企業は、主要な専門家から得られた情報と、企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されています。
アスペンファーマ
フレゼニウス・カビ
アッヴィ
バクスター・ヘルスケア
B.Braun
マルイシ
ピラマル
ヒクマ・ファーマシューティカルズ
宜昌人和万象
無名
恒瑞
西安リバン
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの全身麻酔薬市場規模、（2018年～2029年）
2.1.2 全身麻酔薬市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 全身麻酔薬セグメント、タイプ別
2.2.1 プロポフォール
2.2.2 セボフルラン
2.2.3 レミフェンタニル
2.2.4 エトミデート
2.2.5 イソフルラン
2.2.6 その他
2.3 全身麻酔薬市場規模：タイプ別
2.3.1 全身麻酔薬市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの全身麻酔薬市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 全身麻酔薬セグメント、用途別
2.4.1 静脈麻酔薬
2.4.2 吸入麻酔薬
2.5 全身麻酔薬市場規模：用途別
2.5.1 全身麻酔薬市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの全身麻酔薬市場規模、市場シェア（用途別）（2018年～2023年）
3 全身麻酔薬市場規模：プレイヤー別
3.1 全身麻酔薬市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける全身麻酔薬市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける全身麻酔薬市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの全身麻酔薬市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 全身麻酔薬、地域別
4.1 全身麻酔薬市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける全身麻酔薬市場規模成長（2018年〜2023年）
4.3 APACにおける全身麻酔薬市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける全身麻酔薬市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける全身麻酔薬市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける全身麻酔薬市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける全身麻酔薬市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける全身麻酔薬市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける全身麻酔薬市場規模、地域別（2018年〜2023年）
6.2 APACにおける全身麻酔薬市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける全身麻酔薬市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの全身麻酔薬 国別（2018年～2023年）
7.2 ヨーロッパにおける全身麻酔薬市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける全身麻酔薬市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの全身麻酔薬 地域別（2018年～2023年）
8.2 中東・アフリカにおける全身麻酔薬市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける全身麻酔薬市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの全身麻酔薬市場、市場予測
10.1 グローバルの全身麻酔薬、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの全身麻酔薬、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの全身麻酔薬、市場予測
10.1.3 APACの全身麻酔薬、市場予測
10.1.4 ヨーロッパの全身麻酔薬、市場予測
10.1.5 中東・アフリカの全身麻酔薬、市場予測
10.2 アメリカズの全身麻酔薬、市場予測（国別）（2024年～2029年）
10.3 APACの全身麻酔薬、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの全身麻酔薬、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの全身麻酔薬、市場予測（地域別）（2024年～2029年）
10.6 グローバルの全身麻酔薬、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの全身麻酔薬、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 Aspen Pharma
11.1.1 Aspen Pharma：企業情報
11.1.2 Aspen Pharma：全身麻酔薬分野の提供製品
11.1.3 Aspen Pharma：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 Aspen Pharma：主要事業概要
11.1.5 Aspen Pharma：直近の展開
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi：企業情報
11.2.2 Fresenius-Kabi：全身麻酔薬分野の提供製品
11.2.3 Fresenius-Kabi：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.2.4 Fresenius-Kabi：主要事業概要
11.2.5 Fresenius-Kabi：直近の展開
11.3 AbbVie
11.3.1 AbbVie：企業情報
11.3.2 AbbVie：全身麻酔薬分野の提供製品
11.3.3 AbbVie：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 AbbVie：主要事業概要
11.3.5 AbbVie：直近の展開
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare：企業情報
11.4.2 Baxter Healthcare：全身麻酔薬分野の提供製品
11.4.3 Baxter Healthcare：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 Baxter Healthcare：主要事業概要
11.4.5 Baxter Healthcare：直近の展開
11.5 B\.Braun
11.5.1 B\.Braun：企業情報
11.5.2 B\.Braun：全身麻酔薬分野の提供製品
11.5.3 B\.Braun：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.5.4 B\.Braun：主要事業概要
11.5.5 B\.Braun：直近の展開
11.6 Maruishi
11.6.1 Maruishi：企業情報
11.6.2 Maruishi：全身麻酔薬分野の提供製品
11.6.3 Maruishi：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.6.4 Maruishi：主要事業概要
11.6.5 Maruishi：直近の展開
11.7 Piramal
11.7.1 Piramal：企業情報
11.7.2 Piramal：全身麻酔薬分野の提供製品
11.7.3 Piramal：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 Piramal：主要事業概要
11.7.5 Piramal：直近の展開
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals：企業情報
11.8.2 Hikma Pharmaceuticals：全身麻酔薬分野の提供製品
11.8.3 Hikma Pharmaceuticals：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.8.4 Hikma Pharmaceuticals：主要事業概要
11.8.5 Hikma Pharmaceuticals：直近の展開
11.9 Yichang Humanwell
11.9.1 Yichang Humanwell：企業情報
11.9.2 Yichang Humanwell：全身麻酔薬分野の提供製品
11.9.3 Yichang Humanwell：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.9.4 Yichang Humanwell：主要事業概要
11.9.5 Yichang Humanwell：直近の展開
11.10 Nhwa
11.10.1 Nhwa：企業情報
11.10.2 Nhwa：全身麻酔薬分野の提供製品
11.10.3 Nhwa：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.10.4 Nhwa：主要事業概要
11.10.5 Nhwa：直近の展開
11.11 Hengrui
11.11.1 Hengrui：企業情報
11.11.2 Hengrui：全身麻酔薬分野の提供製品
11.11.3 Hengrui：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.11.4 Hengrui：主要事業概要
11.11.5 Hengrui：直近の展開
11.12 Xi'an Libang
11.12.1 Xi'an Libang：企業情報
11.12.2 Xi'an Libang：全身麻酔薬分野の提供製品
11.12.3 Xi'an Libang：全身麻酔薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.12.4 Xi'an Libang：主要事業概要
11.12.5 Xi'an Libang：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
United States market for General Anaesthetic Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for General Anaesthetic Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for General Anaesthetic Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key General Anaesthetic Medication players cover Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals and Yichang Humanwell, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
LPI (LP Information)' newest research report, the “General Anaesthetic Medication Industry Forecast” looks at past sales and reviews total world General Anaesthetic Medication sales in 2022, providing a comprehensive analysis by region and market sector of projected General Anaesthetic Medication sales for 2023 through 2029. With General Anaesthetic Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world General Anaesthetic Medication industry.
This Insight Report provides a comprehensive analysis of the global General Anaesthetic Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on General Anaesthetic Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global General Anaesthetic Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for General Anaesthetic Medication and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global General Anaesthetic Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of General Anaesthetic Medication market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Segmentation by application
Intravenous Anesthetics
Inhalational Anesthetics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global General Anaesthetic Medication Market Size 2018-2029
2.1.2 General Anaesthetic Medication Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 General Anaesthetic Medication Segment by Type
2.2.1 Propofol
2.2.2 Sevoflurane
2.2.3 Remifentanil
2.2.4 Etomidate
2.2.5 Isoflurane
2.2.6 Other
2.3 General Anaesthetic Medication Market Size by Type
2.3.1 General Anaesthetic Medication Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global General Anaesthetic Medication Market Size Market Share by Type (2018-2023)
2.4 General Anaesthetic Medication Segment by Application
2.4.1 Intravenous Anesthetics
2.4.2 Inhalational Anesthetics
2.5 General Anaesthetic Medication Market Size by Application
2.5.1 General Anaesthetic Medication Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global General Anaesthetic Medication Market Size Market Share by Application (2018-2023)
3 General Anaesthetic Medication Market Size by Player
3.1 General Anaesthetic Medication Market Size Market Share by Players
3.1.1 Global General Anaesthetic Medication Revenue by Players (2018-2023)
3.1.2 Global General Anaesthetic Medication Revenue Market Share by Players (2018-2023)
3.2 Global General Anaesthetic Medication Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 General Anaesthetic Medication by Regions
4.1 General Anaesthetic Medication Market Size by Regions (2018-2023)
4.2 Americas General Anaesthetic Medication Market Size Growth (2018-2023)
4.3 APAC General Anaesthetic Medication Market Size Growth (2018-2023)
4.4 Europe General Anaesthetic Medication Market Size Growth (2018-2023)
4.5 Middle East & Africa General Anaesthetic Medication Market Size Growth (2018-2023)
5 Americas
5.1 Americas General Anaesthetic Medication Market Size by Country (2018-2023)
5.2 Americas General Anaesthetic Medication Market Size by Type (2018-2023)
5.3 Americas General Anaesthetic Medication Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC General Anaesthetic Medication Market Size by Region (2018-2023)
6.2 APAC General Anaesthetic Medication Market Size by Type (2018-2023)
6.3 APAC General Anaesthetic Medication Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe General Anaesthetic Medication by Country (2018-2023)
7.2 Europe General Anaesthetic Medication Market Size by Type (2018-2023)
7.3 Europe General Anaesthetic Medication Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa General Anaesthetic Medication by Region (2018-2023)
8.2 Middle East & Africa General Anaesthetic Medication Market Size by Type (2018-2023)
8.3 Middle East & Africa General Anaesthetic Medication Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global General Anaesthetic Medication Market Forecast
10.1 Global General Anaesthetic Medication Forecast by Regions (2024-2029)
10.1.1 Global General Anaesthetic Medication Forecast by Regions (2024-2029)
10.1.2 Americas General Anaesthetic Medication Forecast
10.1.3 APAC General Anaesthetic Medication Forecast
10.1.4 Europe General Anaesthetic Medication Forecast
10.1.5 Middle East & Africa General Anaesthetic Medication Forecast
10.2 Americas General Anaesthetic Medication Forecast by Country (2024-2029)
10.2.1 United States General Anaesthetic Medication Market Forecast
10.2.2 Canada General Anaesthetic Medication Market Forecast
10.2.3 Mexico General Anaesthetic Medication Market Forecast
10.2.4 Brazil General Anaesthetic Medication Market Forecast
10.3 APAC General Anaesthetic Medication Forecast by Region (2024-2029)
10.3.1 China General Anaesthetic Medication Market Forecast
10.3.2 Japan General Anaesthetic Medication Market Forecast
10.3.3 Korea General Anaesthetic Medication Market Forecast
10.3.4 Southeast Asia General Anaesthetic Medication Market Forecast
10.3.5 India General Anaesthetic Medication Market Forecast
10.3.6 Australia General Anaesthetic Medication Market Forecast
10.4 Europe General Anaesthetic Medication Forecast by Country (2024-2029)
10.4.1 Germany General Anaesthetic Medication Market Forecast
10.4.2 France General Anaesthetic Medication Market Forecast
10.4.3 UK General Anaesthetic Medication Market Forecast
10.4.4 Italy General Anaesthetic Medication Market Forecast
10.4.5 Russia General Anaesthetic Medication Market Forecast
10.5 Middle East & Africa General Anaesthetic Medication Forecast by Region (2024-2029)
10.5.1 Egypt General Anaesthetic Medication Market Forecast
10.5.2 South Africa General Anaesthetic Medication Market Forecast
10.5.3 Israel General Anaesthetic Medication Market Forecast
10.5.4 Turkey General Anaesthetic Medication Market Forecast
10.5.5 GCC Countries General Anaesthetic Medication Market Forecast
10.6 Global General Anaesthetic Medication Forecast by Type (2024-2029)
10.7 Global General Anaesthetic Medication Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Aspen Pharma
11.1.1 Aspen Pharma Company Information
11.1.2 Aspen Pharma General Anaesthetic Medication Product Offered
11.1.3 Aspen Pharma General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Aspen Pharma Main Business Overview
11.1.5 Aspen Pharma Latest Developments
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Company Information
11.2.2 Fresenius-Kabi General Anaesthetic Medication Product Offered
11.2.3 Fresenius-Kabi General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Fresenius-Kabi Main Business Overview
11.2.5 Fresenius-Kabi Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie General Anaesthetic Medication Product Offered
11.3.3 AbbVie General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Company Information
11.4.2 Baxter Healthcare General Anaesthetic Medication Product Offered
11.4.3 Baxter Healthcare General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Baxter Healthcare Main Business Overview
11.4.5 Baxter Healthcare Latest Developments
11.5 B.Braun
11.5.1 B.Braun Company Information
11.5.2 B.Braun General Anaesthetic Medication Product Offered
11.5.3 B.Braun General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 B.Braun Main Business Overview
11.5.5 B.Braun Latest Developments
11.6 Maruishi
11.6.1 Maruishi Company Information
11.6.2 Maruishi General Anaesthetic Medication Product Offered
11.6.3 Maruishi General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Maruishi Main Business Overview
11.6.5 Maruishi Latest Developments
11.7 Piramal
11.7.1 Piramal Company Information
11.7.2 Piramal General Anaesthetic Medication Product Offered
11.7.3 Piramal General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Piramal Main Business Overview
11.7.5 Piramal Latest Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Information
11.8.2 Hikma Pharmaceuticals General Anaesthetic Medication Product Offered
11.8.3 Hikma Pharmaceuticals General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Hikma Pharmaceuticals Main Business Overview
11.8.5 Hikma Pharmaceuticals Latest Developments
11.9 Yichang Humanwell
11.9.1 Yichang Humanwell Company Information
11.9.2 Yichang Humanwell General Anaesthetic Medication Product Offered
11.9.3 Yichang Humanwell General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Yichang Humanwell Main Business Overview
11.9.5 Yichang Humanwell Latest Developments
11.10 Nhwa
11.10.1 Nhwa Company Information
11.10.2 Nhwa General Anaesthetic Medication Product Offered
11.10.3 Nhwa General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Nhwa Main Business Overview
11.10.5 Nhwa Latest Developments
11.11 Hengrui
11.11.1 Hengrui Company Information
11.11.2 Hengrui General Anaesthetic Medication Product Offered
11.11.3 Hengrui General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Hengrui Main Business Overview
11.11.5 Hengrui Latest Developments
11.12 Xi'an Libang
11.12.1 Xi'an Libang Company Information
11.12.2 Xi'an Libang General Anaesthetic Medication Product Offered
11.12.3 Xi'an Libang General Anaesthetic Medication Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Xi'an Libang Main Business Overview
11.12.5 Xi'an Libang Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. General Anaesthetic Medication Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Propofol Table 3. Major Players of Sevoflurane Table 4. Major Players of Remifentanil Table 5. Major Players of Etomidate Table 6. Major Players of Isoflurane Table 7. Major Players of Other Table 8. General Anaesthetic Medication Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 9. Global General Anaesthetic Medication Market Size by Type (2018-2023) & ($ Millions) Table 10. Global General Anaesthetic Medication Market Size Market Share by Type (2018-2023) Table 11. General Anaesthetic Medication Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 12. Global General Anaesthetic Medication Market Size by Application (2018-2023) & ($ Millions) Table 13. Global General Anaesthetic Medication Market Size Market Share by Application (2018-2023) Table 14. Global General Anaesthetic Medication Revenue by Players (2018-2023) & ($ Millions) Table 15. Global General Anaesthetic Medication Revenue Market Share by Player (2018-2023) Table 16. General Anaesthetic Medication Key Players Head office and Products Offered Table 17. General Anaesthetic Medication Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 18. New Products and Potential Entrants Table 19. Mergers & Acquisitions, Expansion Table 20. Global General Anaesthetic Medication Market Size by Regions 2018-2023 & ($ Millions) Table 21. Global General Anaesthetic Medication Market Size Market Share by Regions (2018-2023) Table 22. Global General Anaesthetic Medication Revenue by Country/Region (2018-2023) & ($ millions) Table 23. Global General Anaesthetic Medication Revenue Market Share by Country/Region (2018-2023) Table 24. Americas General Anaesthetic Medication Market Size by Country (2018-2023) & ($ Millions) Table 25. Americas General Anaesthetic Medication Market Size Market Share by Country (2018-2023) Table 26. Americas General Anaesthetic Medication Market Size by Type (2018-2023) & ($ Millions) Table 27. Americas General Anaesthetic Medication Market Size Market Share by Type (2018-2023) Table 28. Americas General Anaesthetic Medication Market Size by Application (2018-2023) & ($ Millions) Table 29. Americas General Anaesthetic Medication Market Size Market Share by Application (2018-2023) Table 30. APAC General Anaesthetic Medication Market Size by Region (2018-2023) & ($ Millions) Table 31. APAC General Anaesthetic Medication Market Size Market Share by Region (2018-2023) Table 32. APAC General Anaesthetic Medication Market Size by Type (2018-2023) & ($ Millions) Table 33. APAC General Anaesthetic Medication Market Size Market Share by Type (2018-2023) Table 34. APAC General Anaesthetic Medication Market Size by Application (2018-2023) & ($ Millions) Table 35. APAC General Anaesthetic Medication Market Size Market Share by Application (2018-2023) Table 36. Europe General Anaesthetic Medication Market Size by Country (2018-2023) & ($ Millions) Table 37. Europe General Anaesthetic Medication Market Size Market Share by Country (2018-2023) Table 38. Europe General Anaesthetic Medication Market Size by Type (2018-2023) & ($ Millions) Table 39. Europe General Anaesthetic Medication Market Size Market Share by Type (2018-2023) Table 40. Europe General Anaesthetic Medication Market Size by Application (2018-2023) & ($ Millions) Table 41. Europe General Anaesthetic Medication Market Size Market Share by Application (2018-2023) Table 42. Middle East & Africa General Anaesthetic Medication Market Size by Region (2018-2023) & ($ Millions) Table 43. Middle East & Africa General Anaesthetic Medication Market Size Market Share by Region (2018-2023) Table 44. Middle East & Africa General Anaesthetic Medication Market Size by Type (2018-2023) & ($ Millions) Table 45. Middle East & Africa General Anaesthetic Medication Market Size Market Share by Type (2018-2023) Table 46. Middle East & Africa General Anaesthetic Medication Market Size by Application (2018-2023) & ($ Millions) Table 47. Middle East & Africa General Anaesthetic Medication Market Size Market Share by Application (2018-2023) Table 48. Key Market Drivers & Growth Opportunities of General Anaesthetic Medication Table 49. Key Market Challenges & Risks of General Anaesthetic Medication Table 50. Key Industry Trends of General Anaesthetic Medication Table 51. Global General Anaesthetic Medication Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 52. Global General Anaesthetic Medication Market Size Market Share Forecast by Regions (2024-2029) Table 53. Global General Anaesthetic Medication Market Size Forecast by Type (2024-2029) & ($ Millions) Table 54. Global General Anaesthetic Medication Market Size Forecast by Application (2024-2029) & ($ Millions) Table 55. Aspen Pharma Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 56. Aspen Pharma General Anaesthetic Medication Product Offered Table 57. Aspen Pharma General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 58. Aspen Pharma Main Business Table 59. Aspen Pharma Latest Developments Table 60. Fresenius-Kabi Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 61. Fresenius-Kabi General Anaesthetic Medication Product Offered Table 62. Fresenius-Kabi Main Business Table 63. Fresenius-Kabi General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 64. Fresenius-Kabi Latest Developments Table 65. AbbVie Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 66. AbbVie General Anaesthetic Medication Product Offered Table 67. AbbVie Main Business Table 68. AbbVie General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 69. AbbVie Latest Developments Table 70. Baxter Healthcare Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 71. Baxter Healthcare General Anaesthetic Medication Product Offered Table 72. Baxter Healthcare Main Business Table 73. Baxter Healthcare General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 74. Baxter Healthcare Latest Developments Table 75. B.Braun Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 76. B.Braun General Anaesthetic Medication Product Offered Table 77. B.Braun Main Business Table 78. B.Braun General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 79. B.Braun Latest Developments Table 80. Maruishi Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 81. Maruishi General Anaesthetic Medication Product Offered Table 82. Maruishi Main Business Table 83. Maruishi General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 84. Maruishi Latest Developments Table 85. Piramal Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 86. Piramal General Anaesthetic Medication Product Offered Table 87. Piramal Main Business Table 88. Piramal General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 89. Piramal Latest Developments Table 90. Hikma Pharmaceuticals Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 91. Hikma Pharmaceuticals General Anaesthetic Medication Product Offered Table 92. Hikma Pharmaceuticals Main Business Table 93. Hikma Pharmaceuticals General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 94. Hikma Pharmaceuticals Latest Developments Table 95. Yichang Humanwell Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 96. Yichang Humanwell General Anaesthetic Medication Product Offered Table 97. Yichang Humanwell Main Business Table 98. Yichang Humanwell General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 99. Yichang Humanwell Latest Developments Table 100. Nhwa Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 101. Nhwa General Anaesthetic Medication Product Offered Table 102. Nhwa Main Business Table 103. Nhwa General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 104. Nhwa Latest Developments Table 105. Hengrui Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 106. Hengrui General Anaesthetic Medication Product Offered Table 107. Hengrui General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 108. Hengrui Main Business Table 109. Hengrui Latest Developments Table 110. Xi'an Libang Details, Company Type, General Anaesthetic Medication Area Served and Its Competitors Table 111. Xi'an Libang General Anaesthetic Medication Product Offered Table 112. Xi'an Libang Main Business Table 113. Xi'an Libang General Anaesthetic Medication Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 114. Xi'an Libang Latest Developments List of Figures Figure 1. General Anaesthetic Medication Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global General Anaesthetic Medication Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. General Anaesthetic Medication Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. General Anaesthetic Medication Sales Market Share by Country/Region (2022) Figure 8. General Anaesthetic Medication Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global General Anaesthetic Medication Market Size Market Share by Type in 2022 Figure 10. General Anaesthetic Medication in Intravenous Anesthetics Figure 11. Global General Anaesthetic Medication Market: Intravenous Anesthetics (2018-2023) & ($ Millions) Figure 12. General Anaesthetic Medication in Inhalational Anesthetics Figure 13. Global General Anaesthetic Medication Market: Inhalational Anesthetics (2018-2023) & ($ Millions) Figure 14. Global General Anaesthetic Medication Market Size Market Share by Application in 2022 Figure 15. Global General Anaesthetic Medication Revenue Market Share by Player in 2022 Figure 16. Global General Anaesthetic Medication Market Size Market Share by Regions (2018-2023) Figure 17. Americas General Anaesthetic Medication Market Size 2018-2023 ($ Millions) Figure 18. APAC General Anaesthetic Medication Market Size 2018-2023 ($ Millions) Figure 19. Europe General Anaesthetic Medication Market Size 2018-2023 ($ Millions) Figure 20. Middle East & Africa General Anaesthetic Medication Market Size 2018-2023 ($ Millions) Figure 21. Americas General Anaesthetic Medication Value Market Share by Country in 2022 Figure 22. United States General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 23. Canada General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 24. Mexico General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 25. Brazil General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 26. APAC General Anaesthetic Medication Market Size Market Share by Region in 2022 Figure 27. APAC General Anaesthetic Medication Market Size Market Share by Type in 2022 Figure 28. APAC General Anaesthetic Medication Market Size Market Share by Application in 2022 Figure 29. China General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 30. Japan General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 31. Korea General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 32. Southeast Asia General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 33. India General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 34. Australia General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 35. Europe General Anaesthetic Medication Market Size Market Share by Country in 2022 Figure 36. Europe General Anaesthetic Medication Market Size Market Share by Type (2018-2023) Figure 37. Europe General Anaesthetic Medication Market Size Market Share by Application (2018-2023) Figure 38. Germany General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 39. France General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 40. UK General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 41. Italy General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 42. Russia General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 43. Middle East & Africa General Anaesthetic Medication Market Size Market Share by Region (2018-2023) Figure 44. Middle East & Africa General Anaesthetic Medication Market Size Market Share by Type (2018-2023) Figure 45. Middle East & Africa General Anaesthetic Medication Market Size Market Share by Application (2018-2023) Figure 46. Egypt General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 47. South Africa General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 48. Israel General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 49. Turkey General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 50. GCC Country General Anaesthetic Medication Market Size Growth 2018-2023 ($ Millions) Figure 51. Americas General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 52. APAC General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 53. Europe General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 54. Middle East & Africa General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 55. United States General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 56. Canada General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 57. Mexico General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 58. Brazil General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 59. China General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 60. Japan General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 61. Korea General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 62. Southeast Asia General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 63. India General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 64. Australia General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 65. Germany General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 66. France General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 67. UK General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 68. Italy General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 69. Russia General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 70. Spain General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 71. Egypt General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 72. South Africa General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 73. Israel General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 74. Turkey General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 75. GCC Countries General Anaesthetic Medication Market Size 2024-2029 ($ Millions) Figure 76. Global General Anaesthetic Medication Market Size Market Share Forecast by Type (2024-2029) Figure 77. Global General Anaesthetic Medication Market Size Market Share Forecast by Application (2024-2029)
